ro 31-8220 has been researched along with Cardiac Hypertrophy in 1 studies
Ro 31-8220: a protein kinase C inhibitor
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Markou, T | 1 |
| Hadzopoulou-Cladaras, M | 1 |
| Lazou, A | 1 |
1 other study available for ro 31-8220 and Cardiac Hypertrophy
| Article | Year |
|---|---|
Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways.
Topics: Adrenergic Agonists; Adrenergic alpha-1 Receptor Agonists; Animals; Atrial Natriuretic Factor; Cardi | 2004 |